Loading...
Loading...
If a pharma company does not possess GMP Certification in India now, then the government will initiate appropriate action against the business, and its licence for the manufacturing of pharmaceutical products will be suspended.
About the Author
Yash Chauhan is a law graduate from the University of Delhi and a skilled content writer at Corpseed. With a keen interest in the legal industry, he specializes in writing articles on contemporary legal developments, corporate compliances, business regulations, environmental circulars, and licensing procedures. His well-researched and insightful content provides valuable information to businesses and individuals navigating the legal landscape.
Related articles
CDSCO Drug License Approval in India: Full Process 2026
2026-04-22
CDSCO Mandates ONDLS Portal for r-DNA Drug License Applications
2026-03-16
New Drug Manufacturing and Clinical Trial Rules Updated in 2026: What You Should Know?
2026-03-13
CDSCO Releases New Guidelines for Compounding of Offences Under the Drugs and Cosmetics Act
2026-02-26
Regulation of Medical Device Pricing and Quality in India: Key Government Measures
2026-02-20
CDSCO Releases Risk Classification List for Oncology Medical Devices
2026-02-12
Maharashtra Unveils Ambitious Renewable Energy & Storage Policy 2025-36
2026-05-18 • 3161 views
2023-02-27
Pregabalin Added Under Schedule H1 Under Drugs (Second Amendment) Rules, 2026
2026-05-22
_Registration_Corpseed.webp&w=1536&q=75)
.png&w=1536&q=75)
